Samsung's Galaxy M17 5G enters the budget segment at Rs 12,499, offering a clean design, a vibrant 6.7-inch Super AMOLED display with a 90Hz refresh rate, and a capable 50MP triple camera. Powered by ...

Overall, I would recommend the M17 5G as a smart, value-for-money pick, a “do-it-all reasonably well” phone. I used the Galaxy M17 5G as my daily phone for a few week, juggling office chats, metro ...

This base configuration is equipped with an Intel Core Ultra 7 265F CPU, GeForce RTX 5080 GPU, 16GB of DDR5 RAM, and a 1TB SSD. You can upgrade to 32GB of RAM for an ...

34-inch size is great for movies, gaming, and work Much better text sharpness than early OLEDs Fantastic gaming performance Simpler, more practical design than predecessor Great out-of-the-box image ...

Yamaha Motor India has filed a trademark for the YZF-R2, hinting at the possibility of a new addition to the R-series lineup, though nothing is confirmed yet. Interestingly, soon after this ...

The new-for-2025 Alienware 16X Aurora gaming laptop is on sale today at a price that's lower than any Black Friday deal. You can pick up a well-specced laptop featuring an Intel Core Ultra 9 CPU and ...

Which bike is best between JHEV Delta R3 vs Ola Electric Gig? As per the users experiences JHEV Delta R3 is a winner for you if you are seriously looking for performance, maintenance and features in ...

A company spokesperson has described the rumours as 'false'. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Update 16 December, 2025: Via a ...

EMotorad T-Rex+ V3 vs JHEV Alfa R3 starts at Rs. 1.25 Lakh which is Rs. 82,000 costlier than base model of at Rs. 42,999. In technical specifications, . EMotorad T-Rex+ V3 is available in 2 different ...

Samsung has long been a dominant player in the smartphone market, catering to various segments with its diverse product lineup. The company expanded its Galaxy A series with the Samsung Galaxy A17 5G, ...

DB Securities on the 15th said Aprilbio is expected to be reappraised for its SAFA platform technology, with results from next year's new drug trials also anticipated to deliver performance. It did ...